Search

Your search keyword '"Waidmann O"' showing total 303 results

Search Constraints

Start Over You searched for: Author "Waidmann O" Remove constraint Author: "Waidmann O"
303 results on '"Waidmann O"'

Search Results

1. Noninvasive screening identifies patients at risk for spontaneous bacterial peritonitis caused by multidrug-resistant organisms

2. Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma

3. Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis

4. Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study

5. 122P Molecular testing, treatment, and response of patients with advanced solid tumors harboring an NTRK gene fusion: Second interim results of the REALTRK registry

9. 1203O FOLFOX plus nivolumab and ipilimumab versus FOLFOX induction followed by nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Results from the randomized phase II Moonlight trial of the AIO

10. 52MO A randomized phase II trial of durvalumab and tremelIMUmab with gemcitabine or gemcitabine and cisplatin compared to gemcitabine and cisplatin in treatment-naïve patients with CHolangio- and gallbladdEr Carcinoma (IMMUCHEC)

11. 1301P Sequential therapy of metastatic pancreatic ductal adenocarcinoma (PDAC) after failure of gemcitabine plus nab-paclitaxel with either 5-FU/folinic acid (5FU/LV) plus irinotecan (FOLFIRI) followed by 5FU/LV plus oxaliplatin (OFF) or the reverse sequence: The PANTHEON trial (AIO PAK 0116)

13. S3 Guideline: Diagnosis and Therapy of Biliary Carcinoma Short Version 2.00-June 2021, AWMF Register Number: 032-053OL

14. S3-Guideline - Diagnosis and Therapy of Biliary Carcinoma

15. Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study

16. S3-Leitlinie – Diagnostik und Therapie biliärer Karzinome

20. Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis

21. S3-Leitlinie – Diagnostik und Therapie biliärer Karzinome

27. Mismatch Reparatur Defizienz, Chemotherapie und Überleben bei resektablem Magenkarzinom: Eine Beobachtungsstudie der deutschen Zentren des staR-Projekts und eine Metaanalyse

28. Multidrug-resistant organisms predispose to relapsing cholangitis in liver graft recipients with stenosis of the biliary anastomosis

31. Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

32. NASH limits anti-tumour surveillance in immunotherapy-treated HCC

37. Epidemiologie von gesicherten bakteriellen Infektionen bei Patienten mit Leberzirrhose in den Jahren von 2010 bis 2019

39. 1525O The QOLIXANE trial - Real life QoL and efficacy data in 1st line pancreatic cancer from the prospective platform for outcome, quality of life, and translational research on pancreatic cancer (PARAGON) registry

40. Geschlechtsabhängige Assoziation von genetischen Varianten von Interleukin 10 und 12 mit dem Verlauf der Hepatitis-B-Virus-Infektion bei kaukasischen Patienten

42. Assoziation von rs16944 im Interleukin-1-beta-Gen mit der Entwicklung eines hepatozellulären Karzinoms in kaukasischen Patienten mit chronischer Virushepatitis

43. IRITACE

44. PD-8 Regorafenib with TAS-102 in metastatic colorectal cancer patients who progressed after at least two standard therapies: Efficacy and safety results of a multicenter phase I study (REMETY)

45. Impact of surface disinfection with hydrogen peroxide on the prevalence of vancomycin-resistant enterococci (VRE) in hospital wards

46. Multiresistente Erreger sind bei Patienten auf der Warteliste zur Lebertransplantation häufig nachweisbar und mit einer erhöhten postoperativen Letalität assoziiert

47. Evaluation of gene expression changes associated with response to somatostatin analogues (SSAs) in gastrointestinal (GI) neuroendocrine tumors (NETs)

49. PD-1 targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicenter real-world cohort

50. Hepatocellular autotaxin is a major source of systemic lysophosphatidic acid and regulates glucose homeostasis

Catalog

Books, media, physical & digital resources